← FDA DRUG APPROVALS

FDA ANDA · ANDA088967

TRIFLUOPERAZINE HYDROCHLORIDE

Sponsor: DURAMED PHARMS BARR

APPLICATION
ANDA088967
TYPE
ANDA
ORIGINAL APPROVAL
1985-04-23
LATEST ACTION
1989-04-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIFLUOPERAZINE HYDROCHLORIDEDiscontinued
TRIFLUOPERAZINE HYDROCHLORIDE EQ 1MG BASE · TABLET · ORAL

Approval history

1989-04-11Labeling · Supplement 9AP
1985-04-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →